Artificial transcription factor
They are generally composed of a DNA-binding domain (specific to a certain sequence) coupled to a modulatory domain (which acts upon other transcription factors) in order to alter the expression of a particular gene. It is also possible to downregulate expression of a gene by targeting the 5' untranslated region with a DNA-binding domain that lacks a regulatory domain; this will reduce transcription simply by blocking RNA polymerase progression along the DNA template.
A very useful library of ATFs has been created and used to induce pluripotency in mouse embryonic fibroblasts.
- Chimera (protein)
- Protein engineering
- Therapeutic gene modulation
- Zinc finger
- Zinc finger protein transcription factor
- Gommans W, Haisma H, Rots M (2005). "Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command" (PDF). J. Mol. Biol. 354 (3): 507–19. doi:10.1016/j.jmb.2005.06.082. PMID 16253273.
- Eguchi, A; et al. (2016). "Reprogramming cell fate with a genome-scale library of artificial transcription factors". PNAS USA. 113: E8257–E8266. doi:10.1073/pnas.1611142114.
|This protein-related article is a stub. You can help Wikipedia by expanding it.|